Do Low-Grade Toxicities Affect Melanoma Treatment Success?
The burden of low-grade toxicity is clinically significant in patients treated with adjuvant pembrolizumab for stage III melanoma.
Medscape Medical News
source https://www.medscape.com/viewarticle/do-low-grade-toxicities-affect-melanoma-treatment-success-2025a10008ca?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/do-low-grade-toxicities-affect-melanoma-treatment-success-2025a10008ca?src=rss
Comments
Post a Comment